Table 2.

Multivariate analysis for predicting progression-free survival.

	Model 1		Model 2
	HR (95% CI)	p-Value	HR (95% CI)	p-Value
Histopathology, clear cell	0.660 (0.380–1.145)	0.13	0.652 (0.378–1.126)	0.12
IMDC score				0.008
Favorable			0.308 (0.133–0.714)	0.006
Intermediate			0.890 (0.508–1.561)	0.68
Poor			Ref.
PNI ≥ 48			0.503 (0.328–0.773)	0.002
Adjusted IMDCC and PNI model		<0.001
Favorable	0.226 (0.099–0.516)	<0.001
Intermediate (PNI-High)	0.484 (0.270–0.866)	0.01
Intermediate (PNI-Low)	1.006 (0.556–1.822)	0.98
Poor	Ref.
Metastasectomy, present	0.680 (0.433–1.068)	0.09	0.683 (0.437–1.067)	0.09
Liver, present	1.436 (0.859–2.401)	0.16	1.518 (0.909–2.533)	0.11